Audible Article by Ohad Etzion M.D., and Marc G. Ghany M.D., M.H.Sc.

Screening for Hepatitis B Virus to Prevent Viral Reactivation —Who and When?

Clinical Liver Disease (CLD), an official digital learning resource of The American Association for the Study of Liver Diseases is an interactive, up-to-date source of education, designed for physicians and healthcare providers caring for the patient with liver disease. CLD provides current and clinically relevant information through educational interventions every two months.

Share Screening for Hepatitis B Virus to Prevent Viral Reactivation —Who and When?

Sign up to save your podcasts

Screening for Hepatitis B Virus to Prevent Viral Reactivation —Who and When?

Screening for Hepatitis B Virus to Prevent Viral Reactivation —Who and When?